Patent Medical to present Symbionic Teeth in Vienna

Osteology Vienna: Corporate symposium focuses on Symbionic Teeth and peri-implantitis prevention

At the International Osteology Symposium in Vienna, speakers Prof. Anton Sculean (left) and Dr Roland Glauser will highlight Symbionic Teeth and the concept of a mucosal defence barrier. (All images: Patent Medical)

Patent Medical

Fri. 17. April 2026

save

VIENNA, Austria: As part of the International Osteology Symposium in Vienna, Patent Medical will host a corporate symposium on Symbionic Teeth on 23 April. The session will feature renowned implantology experts Prof. Anton Sculean and Dr Roland Glauser, who will discuss the Swiss company’s latest tooth replacement concept.

Symbionic teeth are tooth-root-shaped medical devices designed for tooth replacement. Featuring an endosseous and a transmucosal zone, they are anchored in the jawbone and restored with crowns. Unlike traditional dental implants, they form a mucosal defence barrier by bonding with surrounding soft tissue, thereby preventing plaque migration and bacterial invasion.

Natural teeth are protected by a soft-tissue defence barrier that helps limit plaque migration and bacterial invasion. When a tooth is lost, this protective barrier is lost too. According to Patent Medical, the Symbionic Teeth concept is designed to restore this protection by forming a mucosal defence barrier and is intended to address common biological complications associated with implant therapy. A meta-analysis has reported prevalence rates of 43% for peri-implant mucositis and 22% for peri-implantitis.

Attendees of this year’s International Osteology Symposium are invited to join the free corporate symposium on 23 April. The session, titled “Symbionic teeth—next-generation tooth replacement with a mucosal defense barrier to effectively prevent peri-implantitis”, will begin at 5 p.m. CEST in Auditorium 2 at Messe Wien. No separate registration is required.

During the session, the speakers will present scientific evidence on the mucosal defence barrier around Symbionic Teeth and discuss treatment outcomes associated with the concept, including soft-tissue health, peri-implantitis prevention and aesthetic stability over time.

More information about the corporate symposium is available at www.mypatent.com.